Plans to continue expanding in Europe, Asia and Americas
Marken (London; US HQ in New York) has opened a purpose-built, GMP-compliant facility in Argentina to handle the 1,200 clinical trials it is currently providing services for in Latin America, and as a platform for future growth in the region; another facility was opened previously in Mexico City. The new facility includes a full range of temperature controlled storage (ambient, refrigerated and frozen); a secure area for controlled substances; and pick&pack, relabeling, reverse logistics; and specimen kit distribution and storage.
Marken’s distribution network handles 6,000 clinical trials globally, according to the company, and is emphasizing its access to “treatment naïve” geographies around the world. Although the current emphasis is on clinical trials support, the company is also building capabilities for handling commercial distribution and logistics, especially for biologic products. Temperature-controlled shipping options the company provides for APIs and finished goods include Envirotainer containers and unit-load devices (ULDs); Luftansa UniCooler ULDs, and containers from Acutemp, Minnesota Thermal Science, Kryotrans and Laminar Medica.
Protecting Temperature-Sensitive Pharmaceuticals, Without Unnecessary Plastic Waste
March 24th 2025Advances in the life sciences are driving a significant increase in the number of temperature-sensitive pharmaceuticals. The packaging industry is meeting the moment with advances of its own, including high-performance, environmentally-friendly materials that allow life science companies meet stringent thermal requirements and ambitious CO2e reduction goals. In this episode, TemperPack’s CEO Peter Wells shares insights from working with life sciences to move to certified biobased, home compostable, and curbside recyclable shipping solutions.